January 29, 2020 / 11:40 PM / 21 days ago

United Therapeutics notches win in fight over blocked generic rival

United Therapeutics Corp can continue to restrict how pharmacies dispense delivery devices for its cardiovascular drug Remodulin, a New Jersey federal judge ruled on Wednesday, dealing a setback to Novartis AG’ Sandoz generic drug unit.

U.S. District Judge Brian Martinotti denied Sandoz’s request for a preliminary injunction that would have lifted United Therapeutic’s restrictions on pumps and cartridges used to administer the drug.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/37EE7Os

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below